Clinomic secures EUR 23 million in Series B funding round with support from HEUKING

A HEUKING team led by Cologne-based Partner Dr. Oliver Böttcher and Salaried Partner Mark Rossbroich legally advised med-tech startup Clinomic GmbH on successfully closing a EUR 23 million Series B funding round. The round was backed by Deep Tech & Climate Fonds (DTCF) and a private family office.

Clinomic GmbH, based in Aachen, was founded in 2019 as a spin-off of RWTH Aachen University. The company develops intelligent assistance systems for intensive care units, with its flagship product “Mona” leveraging artificial intelligence and voice recognition to analyze medical data and support clinical staff. Clinomic’s interdisciplinary team currently includes more than 70 experts.

Counsel to Clinomic GmbH
HEUKING:
Dr. Oliver Böttcher,
Mark Rossbroich, LL. M. (King’s College London) (both Lead, both Venture Capital),
Dr. Ruben A. Hofmann (IP, Media & Technology), all Cologne,
Dr. Frederik Wiemer (Antitrust), Hamburg,
Michael Kömpel,
Meike Daniels,
Stefan Cesar (Venture Capital), all Cologne